Brain Metastasis From Advanced HER2-negative Breast Cancer
1 clinical trials · Condition
◉ Watch Brain Metastasis From Advanced HER2-negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients With Advanced HER2-Negative Breast Cancer With Brain Metastasis (NCT06839560) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-03-01 |
Track Brain Metastasis From Advanced HER2-negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.